EP3228315
PREVENTION OF ADVERSE EFFECTS CAUSED BY CD3 SPECIFIC BINDING DOMAINS
:
EP einkaleyfi: Þýðing ekki lögð inn:
27.10.2011:
25.11.2020:
17159560.6
:
26.10.2031
:
PREVENTION OF ADVERSE EFFECTS CAUSED BY CD3 SPECIFIC BINDING DOMAINS
27.10.2011
25.11.2020
:
Amgen Research (Munich) GmbH:
Staffelseestrasse 2, 81477 München, DE
:
ZUGMAIER, Gerhard:
81477 Muenchen, DE
:
NAGORSEN, Dirk:
81477 Muenchen, DE
:
SCHEELE, Juergen:
81477 Muenchen, DE
:
412229 P:
10.11.2010:
US
:
A61K 31/573, A61K 39/395, C07K 16/28